CN104844624A - 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 - Google Patents
一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 Download PDFInfo
- Publication number
- CN104844624A CN104844624A CN201510175892.3A CN201510175892A CN104844624A CN 104844624 A CN104844624 A CN 104844624A CN 201510175892 A CN201510175892 A CN 201510175892A CN 104844624 A CN104844624 A CN 104844624A
- Authority
- CN
- China
- Prior art keywords
- sulbactam
- eutectic
- sodium
- cefoperazone
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/04—Preparation
- C07D499/18—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510175892.3A CN104844624B (zh) | 2015-04-14 | 2015-04-14 | 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510175892.3A CN104844624B (zh) | 2015-04-14 | 2015-04-14 | 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104844624A true CN104844624A (zh) | 2015-08-19 |
CN104844624B CN104844624B (zh) | 2016-04-06 |
Family
ID=53844655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510175892.3A Active CN104844624B (zh) | 2015-04-14 | 2015-04-14 | 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104844624B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107080750A (zh) * | 2017-04-26 | 2017-08-22 | 四川制药制剂有限公司 | 注射用头孢哌酮钠舒巴坦钠制备工艺 |
CN111060621A (zh) * | 2019-12-20 | 2020-04-24 | 北京悦康科创医药科技股份有限公司 | 一种注射用头孢哌酮钠舒巴坦钠有关物质的检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143146A (zh) * | 2006-09-13 | 2008-03-19 | 成都博奥通科技有限责任公司 | 头孢哌酮钠与舒巴坦钠组合物 |
CN101249092A (zh) * | 2008-04-10 | 2008-08-27 | 黄芝芳 | 一种抗感染的含有最佳配比的头孢哌酮钠和舒巴坦钠的药物组合物及其制备方法 |
CN101297809A (zh) * | 2008-06-12 | 2008-11-05 | 齐鲁安替制药有限公司 | 头孢哌酮钠与舒巴坦钠混粉的制备方法 |
-
2015
- 2015-04-14 CN CN201510175892.3A patent/CN104844624B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143146A (zh) * | 2006-09-13 | 2008-03-19 | 成都博奥通科技有限责任公司 | 头孢哌酮钠与舒巴坦钠组合物 |
CN101249092A (zh) * | 2008-04-10 | 2008-08-27 | 黄芝芳 | 一种抗感染的含有最佳配比的头孢哌酮钠和舒巴坦钠的药物组合物及其制备方法 |
CN101297809A (zh) * | 2008-06-12 | 2008-11-05 | 齐鲁安替制药有限公司 | 头孢哌酮钠与舒巴坦钠混粉的制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107080750A (zh) * | 2017-04-26 | 2017-08-22 | 四川制药制剂有限公司 | 注射用头孢哌酮钠舒巴坦钠制备工艺 |
CN111060621A (zh) * | 2019-12-20 | 2020-04-24 | 北京悦康科创医药科技股份有限公司 | 一种注射用头孢哌酮钠舒巴坦钠有关物质的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104844624B (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2578596A1 (en) | Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof | |
CN103012430B (zh) | 美洛西林钠化合物及其药物组合物 | |
CN102875576A (zh) | 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法 | |
CN102898438B (zh) | 哌拉西林钠与舒巴坦钠共晶及其制备方法、以及包含该共晶的药物组合物及其应用 | |
CN104844624B (zh) | 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 | |
CN103524532B (zh) | 一种头孢唑肟钠化合物晶型、制备方法及其药物制剂 | |
CN111517980A (zh) | N-[8-(2-羟基苯甲酰基)氨基]辛酸一钾晶型化合物、制备方法及用途 | |
CN104873501A (zh) | 一种治疗感染性疾病的舒巴坦钠组合物 | |
CN104958318A (zh) | 一种治疗感染性疾病的药物舒巴坦钠组合物 | |
CN102942577B (zh) | 一种含有头孢西丁钠化合物的药物组合物 | |
CN104788421A (zh) | 一种治疗呼吸道炎症的厄多司坦化合物及其制备方法 | |
AU2012389714B2 (en) | Cocrystal of piperacillin sodium and sulbactam sodium and preparation method thereof, as well as pharmaceutical compositions containing same and uses thereof | |
CN103145736A (zh) | 一种含有头孢孟多酯钠化合物的药物组合物 | |
CN103622916B (zh) | 一种头孢克肟干混悬制剂及其制备方法 | |
CN106432274A (zh) | 一种治疗外科手术感染的药物头孢曲松钠晶体化合物 | |
CN106397455B (zh) | 一种抗感染药物头孢布烯晶体化合物及其组合物 | |
CN103304604B (zh) | 一种克林霉素磷酸酯化合物,其制备方法及其药物组合物 | |
CN103724359B (zh) | 一种无定形头孢替坦酸及由其制备头孢替坦二钠的方法和含有该头孢替坦二钠的药物组合物 | |
CN106420760A (zh) | 一种治疗外科手术感染的药物头孢布烯组合物 | |
CN106397457A (zh) | 一种治疗外科手术感染的药物头孢布烯晶体化合物 | |
CN103110624A (zh) | 一种阿莫西林钠与克拉维酸钾的药物组合物 | |
CN106420617A (zh) | 一种治疗外科手术感染的药物头孢布烯粉针剂 | |
CN106432271A (zh) | 一种治疗外科手术感染的药物头孢布烯晶体化合物 | |
CN106432275A (zh) | 一种制备治疗外科手术感染的药物头孢曲松钠晶体化合物的方法 | |
CN106432270A (zh) | 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Mingxia Inventor after: Yu Wanxiao Inventor after: Li Hua Inventor after: Yang Leixiang Inventor after: Jiang Yanjie Inventor before: Liu Mingxia Inventor before: Li Hua Inventor before: Yang Leixiang Inventor before: Jiang Yanjie |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160225 Address after: Seven of 276017 Shandong province Linyi city Luozhuang District No. 18 Applicant after: Shandong Luo Xin Pharmaceutical Group Plc Applicant after: Luo Xin Biotechnology (Shanghai) Co., Ltd. Applicant after: Shandong Yu Xin pharmaceutcal corporation, Ltd Address before: Seven of 276017 Shandong province Linyi city Luozhuang District No. 18 Applicant before: Shandong Luo Xin Pharmaceutical Group Plc |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 276017 18 Luo Qi Road, Luozhuang District, Linyi, Shandong Co-patentee after: Luoxin Pharmaceutical (Shanghai) Co., Ltd. Patentee after: Shandong Luo Xin Pharmaceutical Group Plc Co-patentee after: Shandong Yu Xin pharmaceutcal corporation, Ltd Address before: 276017 18 Luo Qi Road, Luozhuang District, Linyi, Shandong Co-patentee before: Luo Xin Biotechnology (Shanghai) Co., Ltd. Patentee before: Shandong Luo Xin Pharmaceutical Group Plc Co-patentee before: Shandong Yu Xin pharmaceutcal corporation, Ltd |